Effects of different types of allogeneic hematopoietic stem cell transplantation donors on Philadelphia chromosome-positive acute lymphoblastic leukemia during the tyrosine kinase inhibitor era: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Effects of different types of allogeneic hematopoietic stem cell transplantation donors on Philadelphia chromosome-positive acute lymphoblastic leukemia during the tyrosine kinase inhibitor era: A systematic review and meta-analysis

Published:2021-10 Issue: Volume: Page:
ISSN:1658-3876
Container-title:Hematology/Oncology and Stem Cell Therapy
language:en
Short-container-title:Hematology/Oncology and Stem Cell Therapy

Author:

Ponvilawan Ben^ORCID,Owattanapanich Weerapat,Charoenngam Nipith^ORCID,Kungwankiattichai Smith^ORCID

Publisher

Elsevier BV

Subject

Oncology,Hematology,General Medicine

Reference32 articles.

1. Philadelphia-positive acute lymphoblastic leukemia: current treatment options;Liu-Dumlao;Curr Oncol Rep,2012

2. Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: current treatments and future perspectives;Yilmaz;Clin Adv Hematol Oncol,2018

3. Philadelphia chromosome-positive leukemia stem cells in acute lymphoblastic leukemia and tyrosine kinase inhibitor therapy;Thomas;World J Stem Cells,2012

4. Chemotherapy-phased imatinib pulses improve long-term outcome of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: Northern Italy Leukemia Group protocol 09/00;Bassan;J Clin Oncol,2010

5. Autologous transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia achieves outcomes similar to allogeneic transplantation: results of CALGB Study 10001 (Alliance);Wetzler;Haematologica,2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of the mechanism of USP28-mediated IFITM3 elevation in BCR-ABL-dependent imatinib resistance in CML;Biomedicine & Pharmacotherapy;2024-04

2. In 2022, which is preferred: haploidentical or cord transplant?;Hematology;2022-12-09